Home
Resources
Publications
Mitochondrial DNA Methylation as a Next-Generation Biomarker and Diagnostic Tool

Mitochondrial DNA Methylation as a Next-Generation Biomarker and Diagnostic Tool

Vito Iacobazzi, Alessandra Castegna, Vittoria Infantino, Generoso Andria

Mol Genet Metab. Sep-Oct 2013;110(1-2):25-34.

PMID: 23920043

Abstract:

Recent expansion of our knowledge on epigenetic changes strongly suggests that not only nuclear DNA (nDNA), but also mitochondrial DNA (mtDNA) may be subjected to epigenetic modifications related to disease development, environmental exposure, drug treatment and aging. Thus, mtDNA methylation is attracting increasing attention as a potential biomarker for the detection and diagnosis of diseases and the understanding of cellular behavior in particular conditions. In this paper we review the current advances in mtDNA methylation studies with particular attention to the evidences of mtDNA methylation changes in diseases and physiological conditions so far investigated. Technological advances for the analysis of epigenetic variations are promising tools to provide insights into methylation of mtDNA with similar resolution levels as those reached for nDNA. However, many aspects related to mtDNA methylation are still unclear. More studies are needed to understand whether and how changes in mtDNA methylation patterns, global and gene specific, are associated to diseases or risk factors.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP220797160	TFB		220797-16-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: